J. R. Passweg, H. Baldomero, and P. Bader, Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplantation activity survey report, Bone Marrow Transplant, vol.53, issue.9, pp.1139-1148, 2018.

E. Ayala, Hematopoietic cell transplantation for B-cell lymphoma: an update, Cancer Control, vol.19, pp.175-186, 2012.
DOI : 10.1177/107327481201900302

L. Bourgeois, A. Labopin, M. Blaise, and D. , Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Soci et e Francophone de Greffe de Moelle et de Th erapie Cellulaire, Ann Oncol, vol.28, pp.2191-2198, 2017.

S. F. Barrington, N. G. Mikhaeel, and L. Kostakoglu, Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group, J Clin Oncol, vol.32, pp.3048-3058, 2014.

E. Jabbour, C. Hosing, and G. Ayers, Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma, Cancer, vol.109, pp.2481-2489, 2007.
DOI : 10.1002/cncr.22714

A. J. Moskowitz, J. Yahalom, and T. Kewalramani, Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma, Blood, vol.116, pp.4934-4937, 2010.
DOI : 10.1182/blood-2010-05-282756

URL : http://www.bloodjournal.org/content/116/23/4934.full.pdf

R. Devillier, D. Coso, and L. Castagna, Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy, Haematologica, vol.97, pp.1073-1079, 2012.

K. Spaepen, S. Stroobants, and P. Dupont, Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation, Blood, vol.102, pp.53-59, 2003.

J. Svoboda, C. Andreadis, and R. Elstrom, Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation, Bone Marrow Transplant, vol.38, pp.211-216, 2006.
DOI : 10.1038/sj.bmt.1705416

URL : https://www.nature.com/articles/1705416.pdf

A. Becherer, M. Mitterbauer, and U. Jaeger, Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation, Leukemia, vol.16, pp.260-267, 2002.

G. T. Sucak, Z. N. Ozkurt, and E. Suyani, Early post-transplantation positron emission tomography in patients with Hodgkin lymphoma is an independent prognostic factor with an impact on overall survival, Ann Hematol, vol.90, pp.1329-1336, 2011.

G. A. Ulaner, D. A. Goldman, and C. S. Sauter, Prognostic value of FDG PET/CT before Allogeneic and autologous stem cell transplantation for aggressive lymphoma, Radiology, vol.277, pp.518-526, 2015.
DOI : 10.1148/radiol.2015142556

URL : http://europepmc.org/articles/pmc5006668?pdf=render

J. R. Lambert, J. B. Bomanji, and K. S. Peggs, Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma, Blood, vol.115, pp.2763-2768, 2010.

C. S. Sauter, L. Lechner, and M. Scordo, Pretransplantation fluorine-18-deoxyglucoseÀpositron emission tomography scan lacks prognostic value in chemosensitive B cell non-hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantation, Biol Blood Marrow Transplant, vol.20, pp.881-884, 2014.
DOI : 10.1016/j.bbmt.2014.02.009

URL : https://doi.org/10.1016/j.bbmt.2014.02.009

V. Bachanova, L. J. Burns, and K. W. Ahn, Impact of pretransplantation (18)Ffluorodeoxy glucose-positron emission tomography status on outcomes after allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma, Biol Blood Marrow Transplant, vol.21, pp.1605-1611, 2015.

Y. Reyal, I. Kayani, and A. Bloor, Impact of pretransplantation (18)F-fluorodeoxyglucose-positron emission tomography on survival outcomes after t cell-depleted allogeneic transplantation for Hodgkin lymphoma, Biol Blood Marrow Transplant, vol.22, pp.1234-1241, 2016.
DOI : 10.1016/j.bbmt.2016.03.034

URL : https://doi.org/10.1016/j.bbmt.2016.03.034

E. Magnusson, Q. Cao, and M. A. Linden, Hematopoietic cell transplantation for mantle cell lymphoma: predictive value of pretransplant positron emission tomography/computed tomography and bone marrow evaluations for outcomes, Clin Lymph Myeloma Leuk, vol.14, pp.114-121, 2014.

A. Yoshimi, K. Izutsu, and M. Takahashi, Conventional allogeneic hematopoietic stem cell transplantation for lymphoma may overcome the poor prognosis associated with a positive FDG-PET scan before transplantation, Am J Hematol, vol.83, pp.477-481, 2008.
DOI : 10.1002/ajh.21158

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.21158

A. Dodero, R. Crocchiolo, and F. Patriarca, Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation, Cancer, vol.116, pp.5001-5011, 2010.

G. A. Ulaner, J. Lilienstein, M. G?-onen, J. Maragulia, and C. H. Moskowitz, Zelenetz AD. False-positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma, J Clin Oncol, vol.32, pp.51-56, 2014.

R. J. Van-kampen, C. Canals, and H. C. Schouten, Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large Bcell pi re 3jnon-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry, J Clin Oncol, vol.29, pp.1342-1348, 2011.

A. Sirvent, N. Dhedin, and M. Michallet, Low non-relapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Soci et eFrançaise de Greffe de Moelle et de Th erapieCellulaire, Biol Blood Marrow Transplant, vol.16, pp.78-85, 2010.

B. D. Cheson, R. I. Fisher, and S. F. Barrington, Recommendations for initial evaluation, staging, and response assessment of Hodgkin and nonHodgkin lymphoma: the Lugano classification, J Clin Oncol, vol.32, pp.3059-3068, 2014.

B. D. Cheson, S. J. Horning, and B. Coiffier, Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group, J Clin Oncol, vol.17, p.1244, 1999.

B. D. Cheson, B. Pfistner, and M. E. Juweid, Revised response criteria for malignant lymphoma, J Clin Oncol, vol.25, pp.579-586, 2007.

T. A. Gooley, W. Leisenring, J. Crowley, and B. E. Storer, Estimation of failure probabilities in the presence of competing risks: new representations of old estimators, Stat Med, vol.18, pp.695-706, 1999.

D. P. Hart, I. Avivi, and K. J. Thomson, Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions, Br J Haematol, vol.128, pp.824-829, 2005.

A. In-press,

L. Bouard, Biol Blood Marrow Transplant, vol.00, pp.1-6, 2018.